Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Preferred Stock Liabilities: 2019

Historic Preferred Stock Liabilities for Revolution Medicines (RVMD) over the last 1 years, with Dec 2019 value amounting to $305.1 million.

  • Revolution Medicines' Preferred Stock Liabilities was N/A to $305.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $305.1 million, marking a year-over-year change of. This contributed to the annual value of $305.1 million for FY2019, which is 48.77% up from last year.
  • Latest data reveals that Revolution Medicines reported Preferred Stock Liabilities of $305.1 million as of Q4 2019, which was down 0.00% from $305.1 million recorded in Q3 2019.
  • In the past 5 years, Revolution Medicines' Preferred Stock Liabilities registered a high of $305.1 million during Q3 2019, and its lowest value of $205.1 million during Q1 2019.
  • For the 1-year period, Revolution Medicines' Preferred Stock Liabilities averaged around $277.6 million, with its median value being $300.1 million (2019).